Interferon alfa-2b (Intron A)
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for Interferon alfa-2b (Intron A), covering 2013-05-13 to 2016-05-04. Get the full timeline:
Most recent: Clinical Trial Update: High-Dose Interferon Alfa in Treating Patients With Stage II or Stage III Melanoma [Phase 3]